Two faculty members of the Vanderbilt University School of Medicine have been elected members of the National Academy of Sciences in recognition of their “distinguished and continuing achievements in original research.”
Using computer-aided drug design, Heidi Hamm, Craig Lindsley, and Jens Meiler and their labs generated a novel series of biologically active compounds that can serve as a basis for anti–blood clot preventative drugs.
Vanderbilt researchers have uncovered a potential new way to help curb the rapidly rising worldwide prevalence of metabolic disorders, including obesity and diabetes.
Ege Kavalali and Heidi Hamm collaborated to discover a signaling pathway for how spontaneous release of neurotransmitters can be selectively regulated without disrupting evoked action potentials.
Heidi Hamm and colleagues have reported the first animal model of a "shut-off valve" for neurotransmitter and hormone release through SNARE complex-mediated membrane fusion.
Reducing antidepressants' side effects
VUMC Investigators honored by ASPET
Hamm's lasting impact commended at Flexner Discovery Lecture
Pharmacology reached new heights on Hamm's watch
Hamm to deliver Discovery Lecture June 12
VU researchers report G protein advancement that could lead to more effective drugs
Hamm's research honored by Dutch pharmacology society
Nobel in Chemistry reveals VU ties that bind
Discovery of how G proteins 'turn on' may lead to better drugs